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Activation of proHGF by St14 induces mouse
embryonic stem cell differentiation
Dear Editor,
Embryonic stem cells (ESCs) are capable of unlimited self-
renewal and differentiation, thus generating remarkable
interest in their potential therapeutic use in cell-based tis-
sue engineering and regeneration. Stem cell based therapy
has been considered as the most promising therapeutic
strategy for a range of debilitating diseases (Reynolds and
Lamba, 2014). One key requirement for stem cell differen-
tiation and migration is to overcome existing matrix obsta-
cles, that endowed by multiple mechanisms including tight
junctions, as well as physical properties such as the matrix
geometry, nanotopography, and stiffness, etc. (Guilak et al.,
2009). It was reported that adherent cells showed tensile
stress in the cytoskeleton by exerting contractile forces
which in turn strengthen the stiffness of the matrix (Ingber,
2004). The strategy cells usually employ to disrupt the
matrix obstacle is zymogen cascades mechanism that
usually involved at least two proteolytic reactions that can
explosively amplify the inﬂuence of extracellular signals.
During this process, proteolytic activities of serine pro-
teases, one of the most ubiquitous membrane proteases of
the protease superfamily, play crucial roles by cleaving the
extracellular matrix and enabling the stem cells to translo-
cate to distant target sites (Paule et al., 2015). Facilitating
the activation of extracellular signals is essential for the
extracellular signaling transduction and fate decision of
mESCs, as most growth factors and cytokines are usually
synthesized as latent forms that require activation by the
protease system located on the membrane of stem cells.
Thus, the transmembrane protease system is an indis-
pensable component of the stem cells’ pluripotent program,
as it plays pivotal roles in mESCs differentiation. However,
the roles of transmembrane protease systems and the
impact of interaction between extracellular signals and
membrane protease system on pluripotency and differen-
tiation have not been well characterized, leaving signiﬁcant
data gaps that hinder the therapeutic applications of stem
cell therapy. Herein we explore the impact of interactions
between extracellular signals and the membrane protease
system through a speciﬁc transmembrane serine protease
(St14), and its effect on inducing mESCs differentiation by
activating proHGF, one of the substrates of St14. Once
cleaved at aa495, the single chain proHGF (inert form)
reverts to the active two-chain form of HGF, and mediates a
wide range of signaling pathways by binding to the c-Met
receptor (Nishida and Hirano, 2003). The activation of
proHGF is important in various processes including: pla-
centa development, cancer progression, wound healing,
and liver regeneration (Lee et al., 2010; Nakamura et al.,
2011).
To detect the expression of St14 in both pluripotent stem
cells (PSCs) and MEFs, semi-quantitative PCR and
immunoblotting were performed (Fig. 1A and 1B). Using
these approaches, we demonstrated that St14 was detected
in PSCs, but not in MEFs. This was consistent with the
results of quantitative real time PCR (96 × 96 qRT-PCR)
(Fig. 1C). Although St14 was differentially expressed in
PSCs and MEFs, their differences in the expression pattern
was not as extensive as observed in some core pluripotent
genes, such as Oct4 and Nanog.
In order to better appreciate how St14 functions in PSCs
and to examine whether it was involved in regulating
pluripotency and differentiation, the expression of select
pluripotent and differentiation genes were examined after
St14 was up-regulated in mESCs. The results demonstrated
that over-expression of St14 was correlated with decreased
expression of Oct4, both at the RNA and protein levels, while
Nanog expression was not as signiﬁcantly affected
(Figs. 1D, 1E, and S1). On the other hand, over-expression
of St14 also led to increased expression of the differentiation
genes Tubb3, MyoD1, and Sox17 (Figs. 1F–H and S2). This
suggested that over-expression of St14 may be involved in
the differentiation of mESCs.
As up-regulation of St14 appeared to have an important
role in mESCs differentiation, we investigated its impact on
the activation of its substrate, proHGF, by examining mESCs
differentiation after over-expression of St14 followed by
proHGF treatment. The experimental design utilized treat-
ment groups that were designed as: 1) control plasmid, 2)
St14 plasmid, 3) proHGF treatment, 4) proHGF treatment +
St14 plasmid, and were used to examine the expression of
pluripotent and differentiation genes. The HGF treatment
served as the control group. The baseline level of proHGF
and HGF derived from the medium and/or endogenous
proHGF and HGF were ﬁrstly detected by an ELISA assay,
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in order to establish that they would not affect the mea-
surement of mESCs pluripotency and differentiation in our
assay (Fig. S3).
The simultaneous over-expression of St14 and treatment
with proHGF (Group 4) resulted in a highly signiﬁcant
decrease in the expression of Oct4 and Nanog than what
was observed following either proHGF treatment or overex-
pression of St14 alone (Group 2 and Group 3) (Fig. 1D and
1E). It was notable that the decrease in the expression of
pluripotent genes was comparable to the HGF groups (HGF
vs. Group 4 of proHGF treatment groups). Furthermore,
over-expression of St14 increased the expression of differ-
entiation genes on the order of 15-fold in the presence of
proHGF, compared to either the St14 (Group 2) and proHGF
(Group 3) treatments alone, which were only capable of
increasing the expression of the differentiation genes some
5–8 fold, respectively (Figs. 1F–H and S2). Similar results
were obtained at the protein level (Data not shown). These
results showed that up-regulation of St14 or treatment of
proHGF alone in mESCs resulted in slightly increased
expression of differentiation genes, but only when St14 was
up-regulated can proHGF be maximally effective in inducing
signiﬁcant increases in the expression of the differentiation
genes. This suggests that over-expression of St14 could
facilitate the activation of proHGF and promote mESCs
differentiation.
It has previously been extensively reported that the
proteolytic activity of St14 was adequately controlled by its
cognate kunitz-type inhibitors of serine proteases, HAIs
(hepatocyte growth factor activator inhibitors), including
HAI-1 and HAI-2. HAI-1 is co-expressed with St14 in vari-
ous epithelial cells, and can suppress the proteolytic activity
of St14 by forming stable inhibitor complexes with St14
(Kojima et al., 2008). Functional studies of this inhibition
have been described in various cells, such as tumor cells
(Tsai et al., 2014) and placental trophoblasts (Szabo et al.,
2009). Here the effect of HAIs down-regulation on mESCs
differentiation was examined in the presence of proHGF,
together with HAI-1 and HAI-2 knock-down (KD) treat-
ments. Both HAI-1 and HAI-2 were found to be highly
expressed in mESCs but not in MEFs (Fig. 2A). This was in
accordance with the expression of St14. The effect of HAI’s
KD on pluripotency and differentiation of mESCs in the
presence and absence of proHGF was subsequently
examined. Not surprisingly, the results showed that the KD
of HAIs caused a decrease in the expression of pluripotent
genes while increasing the expression of differentiation
genes (Fig. 2B). The proHGF treatment produced a more
profound decrease in pluripotent genes and increase of
differentiation genes than did the other experimental treat-
ments (Figs. 2C, 2D, and S4). This suggested that the KD
of HAIs had a similar effect as over-expression of St14 in
the presence of proHGF, and both of these processes can
enhance the activation of proHGF and induce the up-reg-
ulation of differentiation genes.
The abilities of ESCs to differentiate into mature cell types
are the prerequisite for their roles in embryonic development
and tissue damage repair. Given this developmental plas-
ticity, ESCs represent huge potential value for both regen-
erative medicine and clinical applications (Whiting et al.,
2015). Although stem cells have signiﬁcant therapeutic
potential, they are highly sensitive to various extracellular
cues and critically modulated by an elaborate network of
cooperation between mESCs and their microenvironment
(Brizzi et al., 2012; Chandra and Lee, 2015). As such, their
developmental fate could be easily changed by the
microenvironment (Liu et al., 2014). Therefore, comprehen-
sive knowledge of the interaction between stem cells and
their pluripotent niche was a necessary ﬁrst step in eventu-
ally harnessing their true therapeutic potential. In the present
study, we explored the interaction between mESCs and their
microenvironment in regulating mESCs pluripotency and
differentiation by taking the transmembrane serine protease
St14 as an example. It was shown to be differentially
expressed in mESCs and MEFs and it mediated mESCs
differentiation by activating inert proHGF. Additionally, the
proteolytic activity of St14 in mESCs appeared to be corre-
lated with KD of their inhibitor HAI-1 and HAI-2. These
results were consistent with the established understanding
that during vertebrate development, cellular migration and
differentiation were closely related to the pericellular/trans-
membrane proteases and their cognate inhibitors (Szabo
and Bugge, 2011).
It is interesting to note that St14 was differentially
expressed between pluripotent stem cells and somatic cells,
and its over expression has a positive effect on mESCs
differentiation. In addition, the St14 inhibitors HAIs were also
highly expressed in mESCs, and the effect of HAIs KD was
in line with the over-expression of St14, possibly indicating
that the activity of St14 in mESCs could be limited by HAIs.
Taken together, it appears that St14 most likely functions as
a potential switch during mESCs differentiation by activating
proHGF. This was also consistent with the observation that
over-expression of St14 alone had no signiﬁcant impact on
mESCs differentiation.
Figure 1. Differential expression of St14 in pluripotent stem
cells and MEFs, as well as its activity following proHGF
treatment. (A and B) The expression of St14 at the RNA and
protein level was detected by semi-quantitative PCR (A) and
immunoblotting (B); (C) Log2 fold change (stem cell lines vs.
MEF) in the pluripotent genes and St14 by 96 × 96 qRT-PCR
analysis. Data have been normalized using a reference gene;
(D and E) The expression of pluripotent genes in the four
treatment groups described in the text; (F–H) The expression of
differential genes in the four treatment groups described in the
text.
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The results of our experiments strongly support our
hypothesis that St14 plays a positive role in inducing mESCs
differentiation by activating proHGF, and notably, this func-
tion could possibly be controlled by manipulating HAIs. In the
future it will be interesting to determine the mechanisms
underlying just how St14/proHGF induces mESCs differen-
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Figure 2. Differential expression of HAIs in R1 and MEF, and their activity associated with proHGF treatment. (A) The
expression of HAIs in mESCs and MEFs; (B) The expression of pluripotent genes Oct4, Nanog, and Sox2 in HAIs-KD mESCs in the
presence and/or absence of proHGF; (C and D) The expression of differentiation genes after KD of HAI-1 and HAI-2 in the absence
(C) or presence of proHGF (D).
LETTER Xiaoshuang Yan et al.










This study was supported by grants from the National Basic
Research Program (973 Program) (Nos. 2014CB964700 and
2014CB964701), the National Science Fund for Distinguished
Young Scholars (81125003), the Research and Innovation Project
of Shanghai Municipal Education Commission (14JC1405700 and
15ZZ059), Science and Technology Committee of Shanghai Munic-
ipality (12XD1406500), Shanghai Leading Academic Discipline
Project (S3201), Shu Guang Project of Shanghai Education Com-
mission (No. 10GG10).
Xiaoshuang Yan, Yan Xue, Yiye Zhou, Yan Cheng, Shang Yin,
Qingwen Ma, and Fanyi Zeng declare that they have no conﬂict of
interest. All institutional and national guidelines for the care and use
of laboratory animals are followed.
Xiaoshuang Yan1,2,3, Yan Xue1,2,3, Yiye Zhou1,2,3,
Yan Cheng1,2, Shang Yin1, Qingwen Ma2,3, Fanyi Zeng1,2,3&
1 Institute of Medical Science, Shanghai Jiao Tong University School
of Medicine, Shanghai 200025, China
2 Shanghai Institute of Medical Genetics, Shanghai Children’s
Hospital, Shanghai Jiao Tong University, Shanghai 200040, China
3 Key Lab of Medical Embryo Molecular Biology, Ministry of Health,
and Shanghai Lab of Embryo and Reproduction Engineering,
Shanghai 200040, China
& Correspondence: fzeng@sjtu.edu.cn (F. Zeng)
OPEN ACCESS
This article is distributed under the terms of the Creative Commons
Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to
the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made.
REFERENCES
Brizzi MF, Tarone G, Deﬁlippi P (2012) Extracellular matrix, integrins,
and growth factors as tailors of the stem cell niche. Curr Opin Cell
Biol 24:645–651
Chandra P, Lee SJ (2015) Synthetic extracellular microenvironment
for modulating stem cell behaviors. Biomark Insights 10:105–116
Guilak F, Cohen DM, Estes BT, Gimble JM, Liedtke W, Chen CS
(2009) Control of stem cell fate by physical interactions with the
extracellular matrix. Cell Stem Cell 5:17–26
Ingber DE (2004) The mechanochemical basis of cell and tissue
regulation. Mech Chem Biosyst 1:53–68
Kojima K, Tsuzuki S, Fushiki T, Inouye K (2008) Roles of functional
and structural domains of hepatocyte growth factor activator
inhibitor type 1 in the inhibition of matriptase. J Biol Chem
283:2478–2487
Lee SL, Huang PY, Roller P, Cho EG, Park D, Dickson RB (2010)
Matriptase/epithin participates in mammary epithelial cell growth
and morphogenesis through HGF activation. Mech Dev 127:82–
95
Liu Y, Fox V, Lei Y, Hu B, Joo KI, Wang P (2014) Synthetic niches for
differentiation of human embryonic stem cells bypassing embry-
oid body formation. J Biomed Mater Res B Appl Biomater
102:1101–1112
Nakamura T, Sakai K, Matsumoto K (2011) Hepatocyte growth factor
twenty years on: much more than a growth factor. J Gastroenterol
Hepatol 26(Suppl 1):188–202
Nishida K, Hirano T (2003) The role of Gab family scaffolding
adapter proteins in the signal transduction of cytokine and growth
factor receptors. Cancer Sci 94:1029–1033
Paule S, Nebl T, Webb AI, Vollenhoven B, Rombauts LJ, Nie G
(2015) Proprotein convertase 5/6 cleaves platelet-derived growth
factor A in the human endometrium in preparation for embryo
implantation. Mol Hum Reprod 21:262–270
Reynolds J, Lamba DA (2014) Human embryonic stem cell
applications for retinal degenerations. Exp Eye Res 123:151–160
Szabo R, Bugge TH (2011) Membrane-anchored serine proteases in
vertebrate cell and developmental biology. Annu Rev Cell Dev
Biol 27:213–235
Szabo R, Hobson JP, Christoph K, Kosa P, List K, Bugge TH (2009)
Regulation of cell surface protease matriptase by HAI-2 is
essential for placental development, neural tube closure and
embryonic survival in mice. Development 136:2653–2663
Tsai CH, Teng CH, Tu YT, Cheng TS, Wu SR, Ko CJ, Shyu HY, Lan
SW, Huang HP, Tzeng SF et al. (2014) HAI-2 suppresses the
invasive growth and metastasis of prostate cancer through
regulation of matriptase. Oncogene 33:4643–4652
Whiting P, Kerby J, Coffey P, da Cruz L, McKernan R (2015)
Progressing a human embryonic stem-cell-based regenerative
medicine therapy towards the clinic. Philos Trans R Soc Lond B
Biol Sci 370:20140375
Electronic supplementary material The online version of this
article (doi:10.1007/s13238-016-0282-5) contains supplementary
material, which is available to authorized users.
Activation of proHGF by St14 induces mouse ESCs differentiation LETTER
© The Author(s) 2016. This article is published with open access at Springerlink.com and journal.hep.com.cn 605
P
ro
te
in
&
C
e
ll
